From Medscape Neurology

Coverage from the

XXIII World Congress of Neurology (WCN)

September 16 - 21, 2017; Kyoto, Japan

September 16 - 21, 2017 Kyoto, Japan
  • Antimalarial Drug May Be Effective Against PML Mefloquine, an antimalarial drug, may control JC virus, the cause of progressive multifocal leukoencephalopathy, a small, preliminary study suggests.
  • Cardiac Effects of Fingolimod in MS Reversible Fingolimod, used to treat multiple sclerosis, dampens cardiac autonomic modulation at rest and during challenges, but this effect appears to be reversible after discontinuation of the drug, a study shows.
  • Subcutaneous Immunoglobulin Effective for Maintenance in CIDP Subcutaneous immunoglobulin is effective and convenient maintenance therapy for chronic inflammatory demyelinating polyneuropathy, the PATH trial has shown. Local reactions decreased with repeat dosing.

Conference News

Popular News from WCN 2015

  • Mirror Therapy Needs Time to Work in Severe Phantom Pain Mirror Therapy Needs Time to Work in Severe Phantom Pain Mirror therapy can rapidly relieve many amputees' phantom limb sensations, but the more severe the initial pain, the more time may be required for the therapy to work, new research shows.
  • Limb Pain May Be Unrecognized Manifestation of Migraine Limb Pain May Be Unrecognized Manifestation of Migraine Children and adults may have limb, chest, or other pain as a manifestation of migraine syndrome. A recent study shows an autosomal dominant inheritance pattern of the condition in one extended family.
  • White Matter Lesions Linked to Rising Plasma Glucose White Matter Lesions Linked to Rising Plasma Glucose White matter hyperintensities are associated with rising plasma glucose levels even below the diabetic range, a study shows, raising the question of optimal glucose levels for different health effects.

Medscape Neurology©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage